(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 22.29% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 99.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.
Seer's revenue in 2025 is $16,377,000.On average, 3 Wall Street analysts forecast SEER's revenue for 2025 to be $967,361,215, with the lowest SEER revenue forecast at $929,425,481, and the highest SEER revenue forecast at $995,813,015. On average, 3 Wall Street analysts forecast SEER's revenue for 2026 to be $1,257,569,579, with the lowest SEER revenue forecast at $1,208,253,125, and the highest SEER revenue forecast at $1,294,556,920.
In 2027, SEER is forecast to generate $1,695,727,306 in revenue, with the lowest revenue forecast at $1,629,228,196 and the highest revenue forecast at $1,745,601,639.